Form 4: Cabaletta Bio CEO Steven Nichtberger Acquires 353,000 Stock Options
SEC Form 4 Filing
Steven Nichtberger, CEO of Cabaletta Bio, Inc., reports the acquisition of 353,000 stock options on March 1, 2024.
Summary
- Steven Nichtberger, the President and CEO of Cabaletta Bio, Inc., filed a Form 4 on March 4, 2024.
- The filing reports the acquisition of 353,000 stock options on March 1, 2024, at an exercise price of $23.97.
- These options vest over time, with 25% vesting on March 1, 2025, and the remainder vesting in twelve substantially equal quarterly installments thereafter, contingent upon continued service.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing related to stock option grants. The CEO's acquisition of options can be seen as a slightly positive indicator of confidence, but it's not a major event.
Positives
- The acquisition of stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- Shareholders may view the CEO's stock option acquisition as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: Acquisition of 353,000 stock options. |
| 03/01/2025 | 25% of the acquired stock options vest. |
| 02/28/2034 | Expiration date of the stock options. |
| 03/04/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.